Vanguard Group 13F: Cuts Align Technology (ALGN) Stake by $20M
Vanguard Group reduces its stake in Align Technology by 1.47%, holding 8.18 million shares.
Reviewed by automated data checks against the source filing. How we make and check alerts
Vanguard Group sold 121,832 shares from its stake in Align Technology, Inc. ($ALGN), a 1.47% decrease, according to a 13F filing with the SEC dated January 29, 2026. It reported 8,179,779 shares worth $1.37 billion at the end of the quarter.
Since the filing, $ALGN is up 7.0% after 1 week, up 15.2% after 1 month and down 10.2% to date (from the $164.12 close on Jan 29, 2026).
ALGN
Align Technology, Inc.
Key Points
- Vanguard Group reduced its holdings in Align Technology by 121,832 shares, a 1.47% decrease, ending with 8,179,779 shares.
- Align Technology's shares are trading at $177.07, with a market cap of $12.52 billion and a P/E ratio of 29.43.
- Analysts maintain a positive outlook with a consensus 'buy' rating and a mean price target of $209.07.
Get $ALGN trade alerts by text
We text you when insiders, Congress or big funds trade $ALGN. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Align Technology, Inc. alert may contain errors. Disclosures
Vanguard Group has trimmed its stake in Align Technology, Inc. (NasdaqGS: ALGN), according to its latest 13F filing with the SEC dated January 29, 2026. The investment firm reduced its position by 121,832 shares, a 1.47% decrease, bringing its total holdings to 8,179,779 shares. The value of this stake is approximately $1.45 billion.
What Changed in Vanguard Group's Align Technology Position
Vanguard Group cut its investment in Align Technology by 121,832 shares, reducing its holdings from 8,301,611 to 8,179,779 shares. This move represents a 1.47% decrease in its position, with the current value of its holdings at about $1.45 billion.
Other Institutional Activity in Align Technology
Several other institutional investors have also adjusted their positions in Align Technology. BlackRock, Inc. trimmed its stake by 70,636 shares, holding 4,289,924 shares valued at $735.4 million. Capital World Investors significantly increased its holdings by 2,581,793 shares, ending with 4,072,296 shares worth approximately $698.1 million. Meanwhile, Capital International Investors reduced its position by 834,019 shares, now holding 3,809,202 shares valued at $653 million. Vanguard Portfolio Management LLC added 3,150,783 shares, resulting in a total of 3,150,783 shares valued at $540.1 million.
Align Technology, Inc. Stock Up 13.1%
Shares of Align Technology (NasdaqGS: ALGN) are trading near $177.07. The company boasts a market cap of $12.52 billion and a P/E ratio of 29.43. Align Technology's stock has a 52-week low of $122.00 and a high of $208.31. The 50-day moving average stands at $173.31, while the 200-day moving average is $159.42. The company's beta is 1.671, indicating a higher volatility compared to the market.
Recent Earnings
Align Technology reported revenue of approximately $4.10 billion, reflecting a growth of 6.2%. The company's earnings per share (EPS) is $5.94, with a net margin of 10.5% and a return on equity (ROE) of 10.8%. The next earnings release is scheduled for April 29, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
1 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.0%. Revenue met estimates.
-
Profit surprise
EBITDA missed by 36 percent. Operating income missed by 13 percent.
-
Pre-earnings setup
Expectations were about average.
-
Analyst signal
1 target raise.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 3.2 points. Positive free cash flow.
Earnings Call Summary
Align reported $1.041 billion in Q1 revenue, up 6.2 percent, with record clear aligner shipments of 686,000 cases. Growth was driven by strong international performance, particularly in EMEA and APAC with double-digit volume increases, while North America remained stable. Management attributed near-term caution to Middle East conflict uncertainty and ongoing macro headwinds affecting consumer demand, but emphasized long-term confidence in digital orthodontics and restorative dentistry expansion through new products like the Invisalign palate expander and treatment planning services.
Guidance Management reaffirmed full year revenue growth of 3 percent to 4 percent and clear aligner volume growth in mid-single digits. They expect Q2 revenue of $1.040 billion to $1.060 billion, up 3 percent to 5 percent year-over-year, with clear aligner volumes up both sequentially and year-over-year.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Align Technology, Inc.
Recent insider transactions at Align Technology include buys and sells on May 20, 2026. Kevin Conroy purchased 1,836 shares, while Mojdeh Poul sold 1,745 shares and also bought 1,836 shares. Susan Siegel acquired 1,745 shares, and Raymond Larkin Jr. bought 2,448 shares. Britt Vitalone sold 1,443 shares.
Analysts Set New Price Targets
On April 30, 2026, Evercore ISI Group maintained its 'buy' rating on Align Technology with a $220 price target. Morgan Stanley kept its 'hold' rating with a $188 target on April 24. Piper Sandler, on April 21, reiterated a 'buy' rating, setting a $235 target. Citigroup initiated coverage with a 'buy' rating and a $240 target on April 15. The consensus among analysts is a 'buy' rating, with a mean price target of $209.07 based on 14 opinions.
About Align Technology
Align Technology, Inc., headquartered in Tempe, Arizona, is a leader in the healthcare sector, specializing in medical instruments and supplies. The company is widely known for its Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners. Led by CEO Joseph M. Hogan, Align Technology operates globally, providing innovative products and services to dental professionals and patients worldwide.
Bottom Line
Vanguard Group's decision to trim its stake in Align Technology reflects a slight repositioning in its portfolio. While this 13F filing provides a snapshot of Vanguard's holdings as of the reporting period, it may not represent the firm's current position. Align Technology continues to capture investor interest with its strong market presence and innovative products.
Related Filing Alerts
Source: Vanguard Group's 13F filing on $ALGN (Jan 29, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Find the original filing: Vanguard Group 13F filings on SEC EDGAR. Written by software, not financial advice. How we make alerts